Win Advisors Inc. Takes $923,000 Position in Intuitive Surgical, Inc. $ISRG

Win Advisors Inc. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, HoldingsChannel reports. The firm bought 1,629 shares of the medical equipment provider’s stock, valued at approximately $923,000.

Other institutional investors have also modified their holdings of the company. Newbridge Financial Services Group Inc. raised its stake in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares during the period. Holos Integrated Wealth LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $25,000. Olistico Wealth LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. Laurel Wealth Advisors LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $31,000. Finally, Turning Point Benefit Group Inc. raised its stake in Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after acquiring an additional 50 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $420.06 on Tuesday. The stock has a market capitalization of $148.77 billion, a price-to-earnings ratio of 50.92, a PEG ratio of 3.59 and a beta of 1.51. Intuitive Surgical, Inc. has a 1-year low of $417.74 and a 1-year high of $603.88. The company has a 50 day moving average price of $469.33 and a 200 day moving average price of $517.03.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same period last year, the firm posted $1.81 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. The Goldman Sachs Group raised their price target on shares of Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, April 22nd. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Barclays set a $651.00 price target on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Raymond James Financial dropped their price target on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 22nd. Finally, Argus decreased their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $581.91.

Insider Activity

In related news, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the sale, the executive vice president owned 6,120 shares of the company’s stock, valued at $2,735,334. The trade was a 6.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,201 shares of company stock valued at $3,034,567 in the last ninety days. 0.60% of the stock is owned by company insiders.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Several recent articles argue that Intuitive Surgical’s competitive moat is strengthening, with bullish commentary calling it a potential long-term “forever” stock. Intuitive Surgical’s Moat Is Getting Stronger — Is This the Closest Thing to a ‘Forever’ Stock?
• Positive Sentiment: Zacks highlighted ISRG as a solid growth stock, pointing to above-average financial growth and continued outperformance potential. Looking for a Growth Stock? 3 Reasons Why Intuitive Surgical (ISRG) is a Solid Choice
• Positive Sentiment: Analyst sentiment remains broadly favorable, with multiple firms maintaining Buy/Outperform ratings and a consensus price target well above the current trading range. Intuitive Surgical stock details and analyst ratings
• Neutral Sentiment: CEO/EVP Gary Loeb sold 400 shares in a pre-arranged Rule 10b5-1 plan. The sale was disclosed to the SEC, but it appears routine rather than a fresh negative signal. Intuitive Surgical (NASDAQ:ISRG) EVP Gary Loeb Sells 400 Shares
• Negative Sentiment: Shares remain weighed down by safety and regulatory concerns, including the FDA’s Class I recall classification for SureForm stapler reloads, which raises the risk of serious procedural complications. Intuitive Surgical slides as investors weigh Class I stapler-reload recall and lingering safety overhang
• Negative Sentiment: Market chatter also points to institutional selling and a wave of insider sales, which may be adding to bearish sentiment around ISRG. Intuitive Surgical (ISRG) Stock Plunges to 52-Week Low Amid Institutional Exodus

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.